Konkurrenz
Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
---|---|---|---|---|---|---|
CPSE:NOVO B
Novo Nordisk A/S
|
895.10 | 0,08% | 20,84% | 3.994.319,12 | 1,04% | 18,25% |
NYSE:PFE
Pfizer
|
28.37 | 9,56% | 40,23% | 160.199,1 | 6,17% | -9,31% |
ENXTPA:SAN
Sanofi
|
88.32 | 20,28% | 39,51% | 110.272,61 | 4,29% | 8,33% |
ASX:CSL
CSL
|
281.20 | 22,07% | 42,93% | 135.890,67 | 1,25% | 7,18% |
TSE:4568
Daiichi Sankyo Company
|
4829.00 | 0% | 0% | 9.259.376,63 | 1,23% | 0% |
TSE:4502
Takeda Pharmaceutical Company
|
4314.00 | 0% | 0% | 6.768.299,1 | 4,32% | 0% |
NasdaqGS:MRNA
Moderna
|
111.98 | -.112,72% | -.108,78% | 42.784,56 | 0% | 0% |
NasdaqGS:BIIB
Biogen
|
230.07 | -15,04% | 0,03% | 33.443,16 | 0% | -10,89% |
XTRA:BAYN
Bayer
|
26.82 | 78,83% | 98,48% | 26.348,61 | 0,42% | 1,47% |
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
149.10 | 0% | 0% | 18.778,52 | 0% | 0% |
NasdaqGS:SRPT
Sarepta Therapeutics
|
121.58 | 0% | 0% | 11.410,94 | 0% | 0% |
OM:SOBI
Swedish Orphan Biovitrum AB (publ)
|
279.60 | -20,31% | 10,91% | 86.434,21 | 0% | -0,96% |
NasdaqGS:IONS
Ionis Pharmaceuticals
|
43.26 | -.150,35% | -.143,74% | 6.374,47 | 0% | 0% |
BME:GRF
Grifols
|
8.48 | 246,49% | 353,36% | 4.763,14 | 0% | -19,25% |
NasdaqGM:NTLA
Intellia Therapeutics
|
29.54 | 0% | 0% | 2.508,38 | 0% | 0% |
TSE:4516
Nippon Shinyaku
|
4556.00 | 0% | 0% | 329.220,38 | 2,74% | 0% |
NasdaqGS:DYN
Dyne Therapeutics
|
25.55 | 0% | 0% | 2.062 | 0% | 0% |
NasdaqGS:DCPH
Deciphera Pharmaceuticals
|
16.54 | 0% | 0% | 1.286,34 | 0% | 0% |
NasdaqGS:BCRX
BioCryst Pharmaceuticals
|
5.32 | 0% | 0% | 1.185,85 | 0% | 0% |
NasdaqGM:WVE
Wave Life Sciences
|
6.80 | 0% | 0% | 768,25 | 0% | 0% |